These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8835109)

  • 61. Bactericidal and morphological effects of amoxicillin on Helicobacter pylori.
    Berry V; Jennings K; Woodnutt G
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1859-61. PubMed ID: 7486933
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test.
    Chaves S; Gadanho M; Tenreiro R; Cabrita J
    J Clin Microbiol; 1999 May; 37(5):1628-31. PubMed ID: 10203543
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In-vitro synergy of paromomycin with metronidazole alone or metronidazole plus hydroxymetronidazole against Helicobacter pylori.
    Meyer JM; Ryu S; Pendland SL; Kanyok TP; Danziger LH
    J Antimicrob Chemother; 1999 Mar; 43(3):403-6. PubMed ID: 10223597
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhancement of bismuth antibacterial activity with lipophilic thiol chelators.
    Domenico P; Salo RJ; Novick SG; Schoch PE; Van Horn K; Cunha BA
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1697-703. PubMed ID: 9257744
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Susceptibility of Helicobacter pylori to metronidazole.
    López-Brea M; Martín E; López-Lavid C; Sanz JC
    Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1082-3. PubMed ID: 1802703
    [No Abstract]   [Full Text] [Related]  

  • 66. Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents.
    Glupczynski Y; Delmee M; Bruck C; Labbe M; Avesani V; Burette A
    Eur J Epidemiol; 1988 Jun; 4(2):154-7. PubMed ID: 3402574
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis and characterisation of bismuth(III) aminoarenesulfonate complexes and their powerful bactericidal activity against Helicobacter pylori.
    Busse M; Trinh I; Junk PC; Ferrero RL; Andrews PC
    Chemistry; 2013 Apr; 19(17):5264-75. PubMed ID: 23536213
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of glycine on Helicobacter pylori in vitro.
    Minami M; Ando T; Hashikawa SN; Torii K; Hasegawa T; Israel DA; Ina K; Kusugami K; Goto H; Ohta M
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3782-8. PubMed ID: 15388434
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells.
    Megraud F; Trimoulet pascale ; Lamouliatte H; Boyanova L
    Antimicrob Agents Chemother; 1991 May; 35(5):869-72. PubMed ID: 1854168
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics.
    Nagate T; Numata K; Hanada K; Kondo I
    J Clin Gastroenterol; 1990; 12 Suppl 1():S135-8. PubMed ID: 2212539
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The susceptibility of Helicobacter pylori to 12 antimicrobial agents, omeprazole and bismuth salts.
    Rubinstein G; Dunkin K; Howard AJ
    J Antimicrob Chemother; 1994 Sep; 34(3):409-13. PubMed ID: 7829415
    [No Abstract]   [Full Text] [Related]  

  • 72. Activity of antibiotics and azole antimycotics against Helicobacter pylori.
    von Recklinghausen G; Di Maio C; Ansorg R
    Zentralbl Bakteriol; 1993 Sep; 280(1-2):279-85. PubMed ID: 8280952
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Differences in susceptibility of Helicobacter pylori to macrolide and other antibiotics in tests using blood agar and albumin agar].
    Ishii E; Kishi T
    Kansenshogaku Zasshi; 1993 Feb; 67(2):137-42. PubMed ID: 8468498
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Culture of Helicobacter pylori under aerobic conditions on solid media.
    Xia HX; Keane CT; O'Morain CA
    Eur J Clin Microbiol Infect Dis; 1994 May; 13(5):406-9. PubMed ID: 8070454
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and structural characterisation of bismuth(III) hydroxamates and their activity against Helicobacter pylori.
    Pathak A; Blair VL; Ferrero RL; Junk PC; Tabor RF; Andrews PC
    Dalton Trans; 2015 Oct; 44(38):16903-13. PubMed ID: 26352159
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 'In vitro' development of metronidazole, erythromycin, amoxicillin and gentamicin resistance in Helicobacter pylori.
    Brenciaglia MI; Fornara AM; Scaltrito MM; Dubini F
    Int J Antimicrob Agents; 1996 Apr; 6(4):223-6. PubMed ID: 18611711
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Is bactericidal activity of amoxicillin against Helicobacter pylori concentration dependent?
    Midolo PD; Turnidge JD; Munckhof WJ
    Antimicrob Agents Chemother; 1996 May; 40(5):1327-8. PubMed ID: 8723498
    [No Abstract]   [Full Text] [Related]  

  • 78. Susceptibility of Helicobacter pylori and pharmacokinetic properties in mice of new 5-nitroimidazole derivatives devoid of mutagenic activity in the Ames test.
    Dubini F; Riviera L; Scaltrito MM; Bellotti MG
    J Chemother; 1993 Jun; 5(3):168-73. PubMed ID: 8371126
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of bismuth subcarbonate against Campylobacter pylori: do citrate ions improve antibacterial activity?
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1990 May; 273(1):33-5. PubMed ID: 2363796
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risks related to lack of standardization of tests to detect in vitro metronidazole resistance in Helicobacter pylori.
    Henriksen TH; Brorson O; Schöyen R; Thoresen T
    Eur J Clin Microbiol Infect Dis; 1996 Jun; 15(6):484-8. PubMed ID: 8839643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.